Implementation of a lynch syndrome screening protocol on colorectal cancer patients 70 years of age and under: the initial Manitoba screening experience
dc.contributor.author | Sexsmith, Laura | |
dc.contributor.examiningcommittee | Ellison, Cynthia (Pathology) Dupré, Marc (Pathology) Singh, Harminder (Internal Medicine) | en_US |
dc.contributor.supervisor | Wightman, Robert (Pathology) | en_US |
dc.date.accessioned | 2017-06-02T15:30:48Z | |
dc.date.available | 2017-06-02T15:30:48Z | |
dc.date.issued | 2017 | |
dc.degree.discipline | Pathology | en_US |
dc.degree.level | Master of Science (M.Sc.) | en_US |
dc.description.abstract | Objective: Assess the ability of a Manitoba instituted Lynch Syndrome (LS), an autosomal dominant cancer syndrome, screening protocol to identify carriers in colorectal cancer (CRC) patients as compared to literature. Methods: Three hundred sixteen CRC resection tumour cases, patient age 70, were screened for a LS profile over 18 months. Immunohistochemistry for mismatch repair deficiency (MMRD), v-raf murine sarcoma viral oncogene homolog B1 sequencing, and microsatellite instability strategies were used to determine a likelihood of LS. Genetic counselling was recommended to suspected carriers. Results: MMRD was reported in 50(16%) cases; 3(0.9%) deficient (d) MutS homolog 6 (MSH6), 8(2.5%), d MutS protein homolog 2 (MSH2)/dMSH6, 5(1.6%) d Postmeiotic segregation increased 2 (PMS2), and 34(10.7%) d MutL homolog 1 (MLH1)/dPMS2. Seventeen patients underwent germline testing; 9(2.8%) LS mutations were identified. Conclusion: A confirmed LS mutation in 2.8% of cases is a percentage comparable to literature and supports continued protocol utilization. | en_US |
dc.description.note | October 2017 | en_US |
dc.identifier.uri | http://hdl.handle.net/1993/32259 | |
dc.language.iso | eng | en_US |
dc.rights | open access | en_US |
dc.subject | Lynch syndrome | en_US |
dc.subject | Screening protocol | en_US |
dc.subject | Mismatch repair proteins | en_US |
dc.subject | Manitoba | en_US |
dc.subject | Colorectal cancer | en_US |
dc.subject | Cancer syndrome | en_US |
dc.subject | Immunohistochemistry | en_US |
dc.subject | Microsatellite instability | en_US |
dc.subject | HNPCC | en_US |
dc.subject | Hereditary nonpolyposis colon cancer | en_US |
dc.title | Implementation of a lynch syndrome screening protocol on colorectal cancer patients 70 years of age and under: the initial Manitoba screening experience | en_US |
dc.type | master thesis | en_US |
local.subject.manitoba | yes | en_US |